Ads
related to: multiple myeloma- Contact a Representative
For Questions and Information
About This Treatment
- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Contact a Representative
Search results
Multiple myeloma: Prognosis by age
Medical News Today· 1 day agoStatistics regarding multiple myeloma (MM) show that the survival rates are lower for older adults. This may stem from a combination of biological...
Q&A: Quadruple therapies and the future of multiple myeloma treatment
Medical Xpress· 11 hours agoOver the last decade, options have evolved from double, to triple to quadruple combination...
Recent FDA committee vote could speed multiple myeloma drug approval
Medical Xpress· 2 days agoThis Landgren-led study, published May 20 in the journal Blood, featured a meta-analysis of a dozen...
UH offers outpatient bone marrow transplants
News Channel 5 Cleveland· 2 days agoUniversity Hospitals is offering outpatient bone marrow transplants for Multiple Myeloma patients. Multiple Myeloma
MRD endpoint expected to usher new era for MM therapies
Clinical Trials Arena via Yahoo Finance· 3 days agoGiven the ODAC’s unanimous stance, the US regulatory agency is expected to use the surrogate...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 15 hours agoBioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing...
People affected by radiation exposure push Congress to extend benefits
South Dakota Searchlight via Yahoo News· 5 hours agoWASHINGTON — A fund to compensate Americans sickened by exposure to atomic bomb tests, uranium...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 13 hours agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Congress to evaluate how to lower prescription prices by increasing competition
WFXT via Yahoo News· 3 days ago“My doctors have me on a four drug combination with a list price of more than one million dollars a...
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WKRN Nashville· 5 days agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg ...
